Melrosum

Liquid extract from thyme herb, the active ingredient in Melrosum, is a herbal product presented as a liquid oral extract for oral use. It is traditionally employed to support respiratory comfort and provide symptomatic relief in adults, particularly during seasonal upper‑respiratory episodes.

GNH USA supplies Melrosum as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies, clinics, and healthcare institutions worldwide, adhering to stringent quality standards and regulatory requirements. The company ensures batch‑to‑batch consistency through validated manufacturing processes and provides comprehensive documentation for regulatory submissions.

Melrosum, a thyme‑based herbal extract, is used to address conditions of the respiratory tract.

- Cough: May help soothe irritated airways and reduce frequency of coughing. - Bronchitis: May support respiratory comfort during acute bronchial inflammation. - Upper respiratory tract infections: May provide symptomatic relief of congestion and throat irritation.

Melrosum may be associated with the following adverse reactions.

Common Side Effects: - Taste alteration: mild bitter or herbal taste. - Gastrointestinal upset: nausea or mild stomach discomfort. - Skin irritation: localized rash or itching at contact. - Headache: transient mild headache.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction with breathing difficulty. - Liver enzyme elevation: abnormal hepatic function tests. - Bronchospasm: unexpected tightening of airway muscles.

When considering Melrosum, observe the following precautions.

- Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: caution advised; monitor infant for adverse effects. - Anticoagulants: may increase bleeding risk; monitor coagulation parameters. - Known thyme allergy: avoid product to prevent hypersensitivity. - Children: use only under medical supervision and appropriate dosing. - Store at ambient temperature: keep in original container, protect from light and moisture.

Potential drug interactions with Melrosum should be reviewed before therapy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Antiplatelet agents (e.g., aspirin): heightened bleeding tendency.

Moderate Interactions (Monitor Closely): - Cytochrome P450 substrates (e.g., statins): possible alteration of drug metabolism. - Hypoglycemic agents: potential enhancement of glucose‑lowering effect. - Sedatives or CNS depressants: possible additive sedation.